Loss of ​beta2-integrin-mediated cytoskeletal linkage reprogrammes dendritic cells to a mature migratory phenotype by Morrison, Vicky Louise et al.
Strathprints Institutional Repository
Morrison, Vicky Louise and James, Martyn John and Grzes, Katarzyna 
and Cook, Peter and Glass, David Gavin and Savinko, Terhi and Lek, 
Hwee San and Gawden-Bone, Christian and Watts, Colin and Millington, 
Owain Richard and MacDonald, Andrew Scott and Fagerholm, Susanna 
Carola (2014) Loss of beta2-integrin-mediated cytoskeletal linkage 
reprogrammes dendritic cells to a mature migratory phenotype. Nature 
Communications, 5. ISSN 2041-1723 , 
http://dx.doi.org/10.1038/ncomms6359
This version is available at http://strathprints.strath.ac.uk/52928/
Strathprints is  designed  to  allow  users  to  access  the  research  output  of  the  University  of 
Strathclyde. Unless otherwise explicitly stated on the manuscript, Copyright © and Moral Rights 
for the papers on this site are retained by the individual authors and/or other copyright owners. 
Please check the manuscript for details of any other licences that may have been applied. You 
may  not  engage  in  further  distribution  of  the  material  for  any  profitmaking  activities  or  any 
commercial gain. You may freely distribute both the url (http://strathprints.strath.ac.uk/) and the 
content of this paper for research or private study, educational, or not-for-profit purposes without 
prior permission or charge. 
Any  correspondence  concerning  this  service  should  be  sent  to  Strathprints  administrator: 
strathprints@strath.ac.uk
1 
 
Loss of beta2-integrin-mediated cytoskeletal linkage reprograms dendritic cells to a mature 
migratory phenotype 
 
Vicky Louise Morrison1,2, Martyn John James2, Katarzyna Grzes1, Peter Cook3, David Gavin Glass4, 5, 
Terhi Savinko2, Hwee San Lek1, Christian Gawden-Bone6, Colin Watts6, Owain Richard Millington4, 
Andrew Scott MacDonald3, Susanna Carola Fagerholm1,2 
 
1Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, 
DD1 9SY, U.K.; 2Institute of Biotechnology, University of Helsinki, Helsinki, Finland; 3Manchester 
Collaborative Centre for Inflammation Research, University of Manchester, Manchester, M13 9NT, 
U.K.; 4Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, 
Glasgow, G4 0RE, U.K.; 5Institute of Photonics, SUPA, University of Strathclyde, Glasgow, G4 0NW, 
U.K.; 6College of Life Sciences, University of Dundee, Dundee, DD1 5EH, U.K. 
 
 
Address for correspondence: Susanna C Fagerholm (s.c.fagerholm@dundee.ac.uk; 
susanna.fagerholm@helsinki.fi). Institute of Biotechnology, P.O. Box 56, 00014 University of Helsinki 
 
Running title: Integrins restrict migratory DC phenotype 
 
  
2 
 
Abstract 
The actin cytoskeleton has been reported to restrict signaling in resting immune cells. Beta2-integrins, 
which mediate adhesion and cytoskeletal organization, are emerging as negative regulators of 
myeloid cell-mediated immune responses, but the molecular mechanisms involved are poorly 
understood. Here, we show that loss of the interaction between beta2-integrins and kindlin-3 
abolishes the actin-linkage of integrins and the GM-CSF receptor in dendritic cells. This leads to 
increased GM-CSF receptor/Syk signaling, and to the induction of a transcriptional program 
characteristic of mature, migratory dendritic cells, accumulation of migratory dendritic cells in lymphoid 
organs, and increased Th1 immune responses in vivo. We observe increased GM-CSF responses 
and increased survival in neutrophils where the interaction between integrin and the cytoskeleton is 
disrupted. Thus, ligand-reinforced beta2-integrin tail interactions restrict cytokine receptor signaling, 
survival, maturation and migration in myeloid cells and thereby contribute to immune homeostasis in 
vivo. 
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Dendritic cells (DCs) function as the main antigen-presenting cells in the immune system. These cells 
are highly mobile and orchestrate immune responses by taking up antigen in the periphery before 
migrating to lymph nodes in both steady state and inflammatory conditions, where antigen is 
presented to T cells. The maturation or differentiation state of the DC determines the outcome of the 
immune response, and DCs control the initiation of helper, cytolytic and regulatory T cell responses in 
vivo. 
Beta2-integrin adhesion receptors are expressed in both T cells and DCs where they play 
strikingly different roles in immune regulation. In T cells, beta2-integrins and their regulation by talin 
and kindlin-3 are required for firm adhesion under conditions of shear flow, and therefore for T cell 
trafficking into lymph nodes and inflammatory sites 1-4. Talin (but not kindlin-3) is required for efficient 
T cell activation in vitro and in vivo 1,2,5. In DCs, beta2-integrins play a very different role, as they are 
not required for DC migration to lymph nodes in steady state 6. Instead, beta2-integrins have been 
described to restrict DC-mediated priming of T cells 7-9 and Th17 differentiation 10, although the 
molecular mechanisms involved have remained unclear. Beta2-integrins have been reported to play a 
regulatory role in macrophages by restricting Toll-like receptor (TLR) signaling through pathways 
dependent on Syk and IL-10 11,12, but have also recently been reported to promote TLR4 signaling in 
endosomes in DCs and DC-mediated T cell activation 13. Therefore, both the roles of beta2-integrins 
in DC signaling and the molecular mechanisms involved in regulation of DC-mediated immune 
responses by beta2-integrins remain unclear.  
Integrins integrate the cell exterior to the actin cytoskeleton, and integrin activation and 
signaling is regulated by the binding of cytoplasmic proteins, such as talin and kindlin-3, to the beta2-
integrin cytoplasmic domain 14-18. Kindlin-3 is an essential integrin regulator which binds to the integrin 
beta-chain cytoplasmic tail through a membrane-distal NPXY domain 19 and a TTT-domain 1. A 
deficiency in kindlin-3 causes Leukocyte Adhesion Deficiency type III (LAD-III), a disorder where 
beta2- and beta3-integrins cannot mediate leukocyte and platelet adhesion. LAD-III patients have a 
similar phenotype to patients with beta2-integrin subunit mutations (LAD-I), in that they suffer 
recurrent infections, with the addition of severe bleeding due to loss of platelet adhesion 16,20. 
Recently, the actin cytoskeleton has been implicated in restriction of signaling in resting 
immune cells, by causing compartmentalization of the plasma membrane and thereby restricting 
mobility of cell surface receptors and associated molecules 21. Whether integrins, the main 
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³LQWHJUDWRUV´RIFHOOH[WHULRUDQGactin cytoskeleton in cells, contribute to this process has remained 
unclear. 
Here, we show that in the absence of beta2-integrins or beta2-integrin-kindlin-3-mediated 
cytoskeletal organization, bone marrow-derived DCs (BMDCs) display loss of association of the GM-
CSF receptor with the actin cytoskeleton, increased GM-CSF receptor signaling and a maturation 
phenotype characteristic of in vivo migratory DCs, which leads to increased Th1 priming. Our data 
reveal a novel function of ligand-reinforced beta2-integrin-tail interactions in the restriction of cytokine 
receptor signaling of myeloid cells, and of myeloid cell survival, maturation and migration in vivo. 
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Results 
The integrin-kindlin link in DCs restricts T cell activation 
To investigate beta2-integrin-mediated regulation of immune responses, we used a mouse model 
which has recently been described where the kindlin-3 binding site in the beta2-integrin cytoplasmic 
domain has been mutated (beta2TTT/AAA integrin knock-in mice) 1. We have previously investigated the 
activation of T cells from beta2TTT/AAA integrin knock-in mice, using in vitro models and in vivo adoptive 
transfer systems with WT DCs to prime T cell responses, and found knock-in T cell activation to be 
normal1. To investigate the role of the integrin-kindlin-3 interaction in DC-mediated immune responses 
in vivo, beta2TTT/AAA integrin knock-in mice were immunized with peptide antigen LQ&RPSOHWH)UHXQG¶V
Adjuvant (CFA) to induce T cell activation by beta2TTT/AAA integrin knock-in DCs. Strikingly, we found 
that the CD4 T cell response generated in both the spleen and the draining (inguinal) lymph nodes of 
beta2TTT/AAA integrin knock-in mice was elevated compared to WT mice (Figure 1A). This result led us 
to investigate the phenotype of beta2TTT/AAA integrin knock-in DCs. 
We assessed the T cell priming ability of knock-in BMDCs in a co-culture system with TCR 
transgenic CD4 T cells specific for the ovalbumin (OVA) 323-339 peptide (OT-II T cells). Resting (non-
TLR activated) peptide-loaded beta2TTT/AAA-integrin knock-in DCs induced higher levels of OT-II T cell 
activation in vitro, as measured by T cell expression of the activation markers CD69, CD25, and CD44 
(Figure 1B). Using optical trapping, we show that knock-in DCs formed weaker antigen-dependent 
contacts with OT-II T cells, at both the initial contact (2min) and at longer (24hr) contact times, 
compared to WT cells (Figure 1C). This reduced adhesion strength is likely due to impaired binding of 
the integrin ligand ICAM-1 on the T cell surface by DC beta2-integrins, as the kindlin-integrin 
interaction has been described to regulate integrin adhesion to ligands 1. Indeed, knock-in DCs 
showed reduced binding to the beta2-integrin ligands ICAM-1 and iC3b (Figure 1D), as well as to 
culture plates (Figure 1E), demonstrating the general importance of beta2-integrin-kindlin-3 
interactions in integrin-mediated cellular adhesion. As has been reported for other cell types carrying 
the TTT/AAA mutation 1, surface expression of beta2-integrins was lower in knock-in DCs 
(Supplementary Figure S1A), likely due to a deficiency in sorting nexin binding to the mutated integrin, 
leading to deficient integrin recycling from endosomes 22. Indeed, treatment of cells with a lysosome 
inhibitor, bafilomycin, completely rescued the integrin surface expression defect in beta2TTT/AAA 
integrin-expressing cells (Supplementary Figure S1B). However, bafilomycin treatment did not rescue 
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cell adhesion to ICAM-1 (Supplementary Figure S1C), confirming that the defect in DC adhesion is 
due to impaired integrin function rather than a deficiency in integrin surface expression. 
Next we investigated CD4 T cell activation in vivo using MHC class II tetramers following the 
adoptive transfer of either WT or knock-in LPS-activated peptide-loaded DCs into WT recipient mice. 
In this system, only the DCs carry the TTT/AAA mutation whilst all other cell types are WT. In 
agreement with the in vitro data, beta2TTT/AAA-integrin knock-in DCs triggered a larger T cell response 
in vivo in the spleen than WT DCs (Figure 1F), although as this experiment used small amounts of 
adoptively transferred DC, which have to survive and migrate in the WT hosts, the CD4 T cell 
response was not upregulated as much as in Figure 1A, as expected. Taken together, these results 
suggest that beta2TTT/AAA-integrin knock-in DCs are pre-disposed to activate T cells without TLR 
stimulation, driving elevated T cell activation in vitro and in vivo, despite showing reduced adhesion to 
integrin ligands and forming weaker antigen-dependent contacts with T cells. 
 
Beta2-integrin knock-in DCs display elevated maturation 
Our results show that adhesion-deficient beta2TTT/AAA-integrin knock-in DCs drive increased T cell 
immune responses in vitro and in vivo. To further investigate the phenotype of knock-in BMDCs, 
expression of surface markers was analyzed by flow cytometry. Surprisingly, expression of MHC class 
II and co-stimulatory molecules CD80, CD86 and CD40 was higher in GM-CSF-cultured, as well as 
LPS-activated, knock-in DCs compared to WT cells (Figure 2A-B). Interestingly, expression of these 
markers showed a dose-dependent increase in response to GM-CSF (Supplementary Figure S2A). 
Bafilomycin treatment of the knock-in DCs, which rescued cell surface expression of TTT/AAA 
integrins, did not inhibit these increased responses to GM-CSF (Supplementary Figure S1D), 
demonstrating that the decreased surface expression of integrins in knock-in DCs was not 
responsible for their active phenotype. In terms of cytokine production by knock-in DCs, IL-12p40 was 
significantly increased with GM-CSF stimulation, whilst IL-12p40, IL-12p70, IL-10, IL-23p19, TNF-
alpha and nitric oxide were elevated following LPS stimulation (Figure 2C and Supplementary Figure 
S2B), indicating that GM-CSF and TLR responses were elevated in knock-in cells. 
As cellular responses to GM-CSF were elevated in beta2TTT/AAA integrin knock-in DCs, we 
went on to investigate GM-CSF signaling in knock-in BMDCs. Surface expression of the GM-CSF 
receptor was slightly increased in knock-in DCs compared to WT cells (Figure 2D). The GM-CSF 
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receptor signals through the JAK/STAT pathway leading to activation of further downstream pathways 
such as MAPK and Akt. Although initial JAK2/STAT5 activation after GM-CSF stimulation was similar 
in WT and KI cells (Figure 2E), GM-CSF signaling was sustained in knock-in DCs, which displayed 
increased levels of p-MAPK, p-p38 and p-Akt downstream of JAK/STAT signaling at a 3h timepoint 
after GM-CSF addition (Figure 2F). Syk has been previously shown to be downstream of beta-
common chain-containing cytokine receptor signaling 23, and we found here that Syk signaling was 
also up-regulated in beta2TTT/AAA integrin-expressing cells downstream of the GM-CSF receptor 
(Figure 2F). TLR (LPS) stimulation did not further increase Syk signaling in these cells, but LPS 
stimulation did result in up-regulation of NFNB and Akt signaling in knock-in DCs, whilst levels of p-
p38 and pErk after LPS stimulation were similar in WT and knock-in cells (Figure 2G). These results 
demonstrate that GM-CSF (and TLR) signaling is up-regulated in DCs where the kindlin-3-integrin link 
has been disrupted. 
 
Knock-in neutrophils show increased responsiveness to GM-CSF 
To investigate whether increased GM-CSF signaling was a general feature in the beta2TTT/AAA integrin 
knock-in mice, we investigated neutrophil GM-CSF responses. Neutrophilia is a significant symptom 
in murine models with defects in adhesion molecules, including the recently developed beta2TTT/AAA 
integrin knock-in mouse 1,24-27. In addition to the previously reported increase in neutrophil numbers in 
the bloodstream of these mice 1, we found neutrophil numbers in the bone marrow of beta2TTT/AAA 
integrin knock-in mice to be significantly elevated compared to WT controls (Supplementary Figure 
S3A). As GM-CSF is known to be vital for neutrophil survival 28, we tested the survival capacity of WT 
and knock-in neutrophils in vitro. The results show significantly increased ex vivo survival of knock-in 
neutrophils, both in the absence of GM-CSF, likely reflecting continuing cellular responses to 
endogenous signals from their environment within tissues of the mice, and in the presence of GM-
CSF (Supplementary Figure S3B). Knock-in neutrophils also showed increased GM-CSF signaling 
(Supplementary Figure S3C). These data demonstrate a more general role for beta2-integrins in the 
regulation of GM-CSF signaling in leukocytes. 
 
Knock-in bone marrow cells show elevated IL-3 response 
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Because the GM-CSF receptor shares the beta-common chain with the IL-3 and IL-5 cytokine 
receptors, we went on to investigate IL-3 responses in myeloid leukocytes. Myeloid leukocytes 
survived in culture without IL-3, but interestingly, beta2-integrin knock-in bone marrow myeloid cell 
proliferation in response to IL-3 was significantly increased compared to WT cells, with a greater 
effect seen at highest IL-3 concentrations (day 4 average MFIs for CFSE in KI cell cultures are 171 at 
0.1ng/ml IL-3; 135 at 1ng/ml IL-3; 110 at 10ng/ml IL-3), although the effects on survival were not very 
substantial (Supplementary Figure S3D). These data indicate that beta2-integrins are especially 
important in the regulation of GM-CSF receptor (and TLR) signaling. In contrast, Flt3 ligand-cultivated 
DCs and M-CSF-cultured macrophages did not display increased activation responses 
(Supplementary Figure S4A-B). Collectively, these results suggest that beta2TTT/AAA integrin knock-in 
myeloid cells are more responsive to GM-CSF/IL-3 family of cytokines than WT cells. 
 
Beta2-integrin knock-in DCs have a mature migratory phenotype 
Our data imply that maturation status is affected in adhesion-deficient beta2TTT/AAA-integrin knock-in 
DCs. To investigate the global effects on gene transcription in these cells, we performed next 
generation sequencing (RNAseq) from WT and beta2TTT/AAA integrin knock-in BMDCs to map the 
transcriptomes. The data reveal that there were significant differences in gene expression between 
WT and knock-in DCs (Figure 3A-B and Supplementary Datasets S1-2). Co-stimulatory molecules 
CD86 and CD40 and cytokines such as IL-12 were confirmed to be upregulated on the transcriptional 
level in knock-in cells (Figure 3B). Also, molecules involved in antigen presentation (MHC class II and 
CIITA), and in the JAK/STAT signaling (JAK2, STAT5, SOCS2) pathway were upregulated, whilst 
components involved in antigen uptake (Sort1, CD68, Stab1) were downregulated in knock-in cells 
(Figure 3B), confirming that the maturation status was indeed affected in knock-in DCs. However, 
antigen uptake was not reduced in knock-in cells (Figure 3C), indicating that the cells can still take up 
antigen although they are in a more mature state. 
Crucially, CCR7, which is essential for DC migration to lymph nodes, was found to be 
significantly upregulated in knock-in DCs, as determined by next generation sequencing (Figure 3B) 
and flow cytometry (Figure 3D). By comparing gene expression profiles to previously described 
profiles of DC populations in vivo 29, it became apparent that there was a significant overlap of the 
transcriptomes of knock-in DC and in vivo migratory DC populations (non-lymphoid tissue cDCs that 
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have migrated to lymph nodes) (Figure 3E and Supplementary Dataset S3). In migratory DCs, beta2-
integrins (Itgb2 and Itgax genes) are downregulated, whilst CCR7 is upregulated; the same is true in 
knock-in DC (where beta2-integrins also display reduced adhesiveness due to the TTT/AAA 
mutation). Functional annotational clustering analysis30 of genes which were upregulated in both 
migratory and knock-in DCs further (Supplementary Dataset S3) further revealed that genes encoding 
for proteins involved in small GTPase signal transduction (such as Arhgef40, Rabgap1l, Net1, 
Rap2b), zinc-finger containing proteins (Cbl-b, Trim24 etc) and certain cell adhesion proteins (VCAM-
1) were common to both types of cells. In contrast, genes encoding for proteins of certain other 
cellular pathways, such as macromolecule catabolic processes (some ubiquitin ligases and 
caspases), were not upregulated in KI DCs but were upregulated in migratory cells. Of the genes that 
were upregulated in both migratory and KI DCs, small GTPases such as Rap2 and cell adhesion 
proteins such as VCAM-1 are well known to regulate cell migration, and Cbl-b has been previously 
described as a negative regulator of beta2-integrin-mediated adhesion 31. Therefore, it appears that 
the non-adherent knock-in DCs had switched on a transcriptional program characteristic of DC 
populations which have matured and migrated to lymph nodes. Thus, the integrin-kindlin link, which is 
essential for DC adhesion to the environment, is crucial for restricting the DC maturation program. 
To investigate whether switching on a transcriptional program characteristic of migratory DCs 
influenced knock-in DC behavior in vivo, we investigated numbers of DCs in lymphoid organs in 
beta2TTT/AAA-integrin knock-in mice. We found that there were indeed significantly increased numbers 
of CD11c+ MHC class II+ DCs in the spleen and peripheral lymph nodes of knock-in animals 
compared to WT controls (Figure 4A). Specifically, numbers of migratory CD11b+ and CD103+ DCs 
were increased in knock-in lymphoid tissues, whereas numbers of CD8+ and CD8- resident DCs were 
unaffected by the TTT/AAA mutation (Figure 4B). T and B cell numbers in lymph nodes were normal 
in naïve knock-in mice1 and in immunized mice (Figure 4C), but DC numbers in lymph nodes were 
increased in both resting and immunized knock-in mice (Figure 4D). In addition, knock-in splenic DCs 
from both resting and immunized mice displayed significantly increased expression of CD86 in vivo, 
and a trend towards elevated CD40 expression, although this did not reach statistical significance 
(Figure 4E). Importantly, following administration of fluorescent OVA antigen into the skin, we found 
increased numbers of OVA+ DCs in the draining lymph nodes 24hrs later (Figure 4F). Therefore, loss 
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of the beta2-integrin-kindlin-3 link in DCs induces a switch to a mature phenotype in vitro and in vivo, 
and induced DC migration to lymph nodes and/or increased survival of KI DCs. 
 
Integrin-kindlin-actin links regulate DC maturation 
Maturation of DCs is well known to be associated with reduced adhesion and changes in cell 
morphology32, and we found that LPS maturation of DCs indeed significantly reduced adhesion to 
integrin ligands (Figure 5A). To investigate whether loss of functional integrins was responsible for 
induction of DC maturation in beta2TTT/AAA integrin knock-in cells, we analyzed signaling and 
maturation status in beta2-integrin null DCs. Similar to the beta2TTT/AAA integrin knock-in DCs, p-Syk 
and p-Akt levels were elevated in GM-CSF-stimulated beta2-integrin null DCs (Figure 5B). These cells 
also expressed more MHC class II, CD80, CD86 and CD40 (Figure 5C), and produced more IL-12p40 
(in response to GM-CSF and LPS) and IL-10 (in response to LPS) than WT cells (Figure 5D). These 
data indicate that the elevated signaling in knock-in DCs is due to the absence of functional beta2-
integrins.  
We next directly assessed the role of integrin-ligand interactions in the regulation of signaling 
and maturation of DCs by comparing adhered WT DCs to WT DCs which were detached and placed 
in tubes. The results show that p-Syk and p-p38 levels were elevated in the detached cells compared 
to adhered cells (Figure 5E). The expression of the co-stimulatory markers CD80, CD86, CD40 and 
MHC class II by WT DCs was significantly increased in detached cells compared to adhered cells 
when stimulated with GM-CSF (Figure 5F). Additionally, production of IL-12p40 and IL-10 was 
increased in detached cells compared to adhered cells following GM-CSF and LPS stimulation, 
respectively (Figure 5G). Together, these results indicate that beta2-integrin-mediated ligand binding 
regulates signaling and maturation in myeloid DCs. To confirm this, we investigated IL-12 production 
(Figure 5H) and CD86 expression (Figure 5I) by WT and knock-in DCs plated on different substrates, 
e.g. beta2-integrin substrates (petri dishes and ICAM-1), a beta1-integrin substrate (fibronectin) and 
tissue culture plates (unspecific substrate). As the knock-in mutation is in the beta2-integrin tail, 
knock-in DCs are not expected to display any abnormality when plated on a beta1-integrin substrate. 
Indeed, knock-in cells on beta2-integrin substrates displayed elevated maturation, whilst knock-in 
DCs on beta1-integrin substrates displayed similar activation to WT cells (Figure 5H-I). These results 
indicate that WT beta2-integrin-mediated ligand binding and/or ligand-reinforced integrin tail 
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interactions provides suppressory signals to the GM-CSF receptor complex, which are lost in KI DCs, 
and that ligand-induced beta1-integrin-mediated signals can compensate for the deficiency in function 
of beta2-integrins in KI cells.  
To directly assess the role of adhesion (rather than integrin-kindlin-3 contacts) in regulation of 
DC signaling, we further investigated whether Mn2+, a traditional extracellular activator of integrin-
mediated adhesion, could rescue KI DC adhesion and at the same time suppress signaling. Although 
Mn2+ treatment of cells did not result in a formal rescue of adhesion, low amounts of Mn2+ did result in 
a slight increase in KI DC adhesion to ICAM-1 and iC3b (Supplementary Figure S5A), but IL-12 
production and CD86 expression were increased rather than decreased after Mn2+ treatment 
(Supplementary Figure S5B). These results show that increased adhesion alone, without 
integrin/kindlin links, was not sufficient to reduce GM-CSF receptor signaling in cells; rather, the 
integrin/kindlin link is required for integrins to suppress GM-CSF receptor signaling in DCs.  
The cortical actin cytoskeleton is known to restrict receptor movement and signaling in 
immune cells 21. Integrin cytoplasmic domains are important in linking the plasma membrane to the 
actin cytoskeleton, and therefore play pivotal roles in actin organization. In addition, the integrin 
TTT/AAA mutation significantly perturbs integrin-mediated actin reorganization in cells 1,14. Therefore, 
we investigated the subcellular localization of the beta2-integrins, kindlin-3 and the GM-CSF receptor 
in DCs. A significant amount of beta2-integrin, kindlin-3, talin and the GM-CSF receptor were 
localized to the cytoskeletal fraction of WT DCs, but the TTT/AAA-mutation of the integrin abolished 
these associations (Figure 6A), indicating that the integrin-kindlin link is essential for actin recruitment 
of beta2-integrins and cytokine receptors. Levels of another membrane receptor, CD9, (a tetraspanin 
which mediates MHC II lateral associations in DCs33) were equivalent in WT and knock-in cytoskeletal 
fractions (Figure 6A), indicating that not all cell surface receptors are regulated in this way. To test 
whether the loss of the integrin-actin link is responsible for the increased signaling in knock-in DCs, 
cells were treated with cytochalasin D to disrupt actin filaments. Cytochalasin D treatment of WT DCs 
resulted in up-regulation of p-Syk and p-MAPK (Figure 6B), as well as an increase in CD86 and CD40 
expression (Figure 6C), and in IL-12p40 production (Figure 6D). Together, these data indicate that 
ligand-reinforced integrin-actin interactions, regulated through kindlin-3, are necessary for the 
regulation of GM-CSF receptor signaling in DCs, and for the regulation of downstream effects 
including DC maturation. 
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Syk is partly responsible for the mature DC phenotype 
Levels of p-Syk were elevated in beta2TTT/AAA-integrin knock-in DCs (Figure 2F). To investigate the 
role of Syk in the elevated DC activation status we made use of the selective Syk inhibitor II 34 and a 
p38 inhibitor (SB203580). Syk inhibition of WT DCs in suspension resulted in a reduction of both co-
stimulatory marker expression (Figure 7A) and cytokine production (Figure 7B), confirming that these 
activation properties of DCs are controlled by GM-CSF-induced Syk activity. Meanwhile, p38 inhibition 
in WT DCs reduced CD80 expression levels (Figure 7A) and IL-10 production (Figure 7B), but not 
CD86, CD40, MHC class II or IL-12p40 (Figure 7A-B), suggesting that the p38 signaling pathway 
downstream of Syk regulates CD80 and IL-10 in GM-CSF-stimulated DCs. In addition, Syk inhibition 
in both beta2-integrin knock-in and null DCs resulted in a partial reduction of IL-12p40 and IL-10 
production (Figure 7C), showing that the active phenotype of knock-in DCs is due, in part, to elevated 
Syk activity. Together, these results reveal that integrin/kindlin-mediated signals negatively regulates 
downstream GM-CSF receptor signaling in DCs, mediated through Syk, which in turn regulates the 
expression of co-stimulatory molecules and production of cytokines.  
 
Beta2-integrin knock-in DCs induce elevated Th1 responses 
 ³0XWHG´'&DFWLYDWLRQhas been associated with Th2 responses, whilst conventionally matured (TLR-
activated) DCs generally promote Th1/Th17 responses 35. In addition, Syk signaling in DCs is 
essential for Th1/Th17 responses in vivo 36,37 To investigate whether beta2TTT/AAA integrin knock-in 
DCs specifically induce Th1/Th17 responses in vivo, WT or knock-in DCs were loaded with antigens 
that have previously been shown to promote differential T helper cell subset polarization following DC 
adoptive transfer 38; the Th2 schistosome soluble egg antigen (SEA), and heat-killed 
Propionibacterium acnes which drives Th1/Th17 responses (Supplementary Figure S6A-B). 
Beta2TTT/AAA integrin knock-in DCs induced greater antigen-specific IFNȖ production by T cells in both 
immunization groups (Figure 8A), indicative of a stronger Th1 response. Conversely, the Th2 
response (identified by IL-4, IL-5, IL-13, and IL-10) was significantly lower in the knock-in DC 
immunization groups, especially for the SEA group, which promoted the largest Th2 response (Figure 
8A). IL-17, indicative of a Th17 response, was only produced at marked levels in the P. acnes antigen 
group, where production was equivalent in the WT and knock-in DC immunization groups (Figure 8A). 
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Polyclonal stimulation confirmed the increased Th1 priming and impaired Th2 responses 
(Supplementary Figure S6C). 
We found increased production of CXCL10, a chemokine that promotes Th1 cell 
differentiation 39, by knock-in DCs compared to WT DCs (Figure 8B), which, together with the 
increased IL-12 production by these cells, may account for the elevated priming of Th1 responses by 
knock-in DCs in vivo. These data therefore demonstrate that beta2TTT/AAA integrin knock-in DCs, which 
show increased signaling and an elevated activation state associated with migratory DCs, specifically 
promote elevated Th1 responses, and are strikingly impaired in their priming of Th2 responses, in 
vivo. 
In conclusion, we show that specific ligand-reinforced integrin tail interactions and integrin-
mediated cytoskeletal organization play an unexpected role in restricting myeloid cell signaling and 
activation, and the maturation program characteristic of migratory DCs, thereby regulating T cell 
immune responses in vivo.  
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Discussion 
Beta2-integrins are emerging as important negative regulators of immune cell signaling, especially in 
myeloid cells, in stark contrast to the mainly positive role that integrins play in growth factor receptor 
signaling in other cell types. As such, beta2-integrins have been described to negatively regulate TLR 
and interferon signaling in macrophages 11,12. In addition, active beta2-integrins in DCs and 
macrophages inhibit their priming of T cells 7. Mechanisms by which beta2-integrins negatively 
regulate signaling are emerging. CD11b-induced Syk activation has been proposed as a mechanism 
to negatively regulate TLR signaling in macrophages 11, and indirect mechanisms involving the 
signaling inhibitor A20 and the anti-inflammatory cytokine IL-10 have also been described 12. 
However, the CD11b-integrin has also recently been reported to instead positively regulate TLR4 
signaling in endosomes in DCs (as opposed to macrophages), and to be required for TLR4-triggered 
responses in vivo 13. In contrast, in this study, we describe that ligand-reinforced beta2-integrin tail 
interactions with kindlin-3 and cytoskeletal coupling negatively regulate DC maturation through 
restricting GM-CSF receptor signaling. Therefore, in DCs, ablating beta2-integrin-mediated 
cytoskeletal organization (through mutation of the kindlin-binding site in the integrin, or beta2-integrins 
themselves) results in a strikingly different phenotype than ablating the CD11b integrin subunit alone, 
likely reflecting redundancy between different beta2-integrins in DCs, as DCs express (at least) 
CD11a- and CD11c-chains in addition to CD11b. 
Interestingly, we found that the integrin/kindlin connection also restricts GM-CSF receptor 
signaling in neutrophils. Neutrophilia is a significant symptom in murine models with defects in 
adhesion molecules 1,24-27; our data suggests that increased GM-CSF receptor signaling in these cells 
may contribute to the significant neutrophilia found in these mouse models. 
Intriguingly, ablating the beta2-integrin/kindlin-3 interaction - results in DC maturation to a 
migratory phenotype, increased DC trafficking to lymph nodes, and increased T cell priming in vivo. 
Reprogramming of DCs to a mature, migratory phenotype by loss of integrin/kindlin links implies that 
beta2-integrins contribute to immune homeostasis by restricting DC maturation in tissues until 
migration and maturation is required. Does loss of ligand-induced integrin signals contribute to DC 
maturation/migration also under physiological conditions? Interestingly, migratory DCs found in lymph 
nodes express less beta2-integrins than their tissue counterparts (Supplementary Dataset S3) 29, 
indicating that under steady state conditions, beta2-integrins are indeed down-regulated when cells 
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migrate to lymph nodes, possibly through a cell-intrinsic effect during the DC life cycle. We speculate 
that beta2-integrins, which are not required for DC migration to lymph nodes in steady state 6, instead 
mediate DC interactions with their extracellular environment in peripheral tissues, which restricts their 
migration to lymph nodes. Loss of ligand-binding due to integrin down-regulation reprograms DCs and 
contributes to migration to lymph nodes under steady-state conditions. In addition, it is well described 
that during DC maturation due to external stimuli, such as TLR stimulation, adhesion is 
downregulated and the cell morphology and actin cytoskeleton is fundamentally altered 32,40, and the 
cells become more migratory40, and we show here that adhesion to integrin-ligands is indeed reduced 
in LPS-matured DCs. Therefore, maturation-induced loss of ligand-binding and/or cytoskeletal 
coupling may promote DCs to switch on the transcriptional program that allows for their migration to 
lymph nodes and for the subsequent activation of T cells. 
The elevated maturation status in DCs lacking beta2-integrin-mediated cytoskeletal 
organization was mediated by increased GM-CSF receptor signaling. The membrane skeleton is 
essential for controlling signaling in resting immune cells 21,41 and integrins act as links or integrators 
between the cell exterior and the cell cytoskeleton in cells 42. They would therefore be well positioned 
IRU IRUPLQJ ³SLFNHWV´ LQ WKH ³SLFNHW-fHQFH´ PRGHO RI WKH SODVPD PHPEUDQH DQG IRU UHVWULFWLQJ
movement of receptors in the plasma membrane 43. We propose that ligand-reinforced integrin-
kindlin- linkages fundamentally restrict the movement of the actin-linked GM-CSF receptor (and 
possibly other receptors or adapter proteins) at the DC plasma membrane, thereby limiting 
downstream signaling, a function of integrins in immune cells that has not previously been 
appreciated (Supplementary Figure S8). We further show that increased GM-CSF receptor-induced 
Syk signaling is, in part, responsible for the elevated activation phenotype in these knock-in DCs. TLR 
responses were also elevated in knock-in DCs, although TLR signaling did not further activate Syk in 
these cells. Interestingly, a complex between the beta-common chain of IL-3/IL-5/GM-CSF receptors 
and the ITAM-containing Fc receptor Ȗ-chain has been previously described, leading to recruitment of 
Syk to the IL-3 receptor in basophils 23; a similar mechanism may be at play in DCs and neutrophils. 
The exact mechanism(s) of integrin-mediated regulation of signaling receptors in DCs need to be 
established in future studies. 
A striking result from this work was that beta2TTT/AAA-integrin knock-in DCs, which displayed 
an elevated activation state, induced elevated Th1 responses in vivo, whilst Th2 priming was 
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impaired. Indeed, highly activated DCs have previously been described to preferentially promote a 
Th1 response44ZKLOVW7KUHVSRQVHVDUHJHQHUDOO\DVVRFLDWHGZLWKD³PXWHG´'&DFWLYDWLRQVWDWH35. 
In addition, Syk signaling in DCs has been previously reported to be essential for Th1 responses in 
vivo 36,37. We show that increased Syk signaling resulted in elevated DC activation and increased IL-
12 production by knock-in DCs, which may explain why these cells were poised to induce Th1, rather 
than Th2, immune responses in vivo, through counter-regulation of Th2 activation. In contrast, other 
Th1 polarizing factors, such as CD7045, although more highly expressed in knock-in DCs, were 
expressed at very low levels and therefore were unlikely to contribute to the Th1 polarization by the 
knock-in DCs. Also, IRF4, a transcription factor in DCs that has recently been described to be 
essential for Th2 development46, was not different between WT and knock-in cells. However, the GM-
CSF-cultured knock-in DCs produced more CXCL10, a chemokine which has been shown to be 
involved in DC-dependent Th1 responses in vivo 39; CXCL10 production was also dependent on Syk. 
Th17 priming by the knock-in DCs was normal, likely reflecting the observation that production of IL-6, 
the key cytokine that drives Th17 differentiation in this model 47, was minimally affected by the knock-
in mutation. 
Beta2-integrins have been shown to promote tolerance 10, suppress colitis and dermatitis 48,49 
and protect against endotoxic shock 11, consistent with regulatory and homeostatic roles of these 
integrins in immune responses in vivo. In addition, autoimmune colitis has been reported in several 
LAD-I patients, further supporting the notion that the absence of beta2-integrin-mediated function in 
vivo results in unregulated immune responses 50-52. Beta2-integrins, therefore, play dual roles in the 
immune system as they influence both the recruitment of leukocytes to sites of inflammation, as well 
as the regulation of inflammatory responses by restricting signaling in myeloid cells when they interact 
with their environment. Our report has unraveled novel roles of beta2-integrins in immune cell 
functions, and has demonstrated that the beta2-integrin-kindlin-3 interaction, in addition to regulating 
T cell adhesion and homing 1, also plays an unexpected role in restricting GM-CSF-induced Syk 
signaling, the transcriptional program characteristic of mature migratory DCs, and in regulating 
Th1/Th2 immune responses. Our results therefore expand on current models of how beta2-integrins 
regulate immune homeostasis. In addition, the induction of a migratory DC phenotype by targeting 
beta2-integrins may be of use in the design of more effective dendritic cell-based immunotherapies. 
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Materials and Methods 
 
Mice 
Mice were maintained in the Wellcome Trust Biocentre at the University of Dundee, the School of 
Biological Sciences, University of Edinburgh, or the University of Helsinki, Finland, in compliance with 
UK Home Office Animals (Scientific Procedures) Act 1986 and the Finnish Act on Animal 
Experimentation (62/2006), respectively. Animal experiments were approved by the Home office (UK) 
and the national Animal Experiment Board (Finland), respectively. We have previously generated the 
novel Itgb2 knock-in mice 1. C57Bl/6 mice were obtained from Charles River and beta2 null mice from 
JAX (catalogue number 003329). Age- and sex-matched male or female mice aged 8-12 weeks were 
used in experiments. 
 
Leukocyte isolation and culture  
DCs were generated by culturing bone marrow for 10 days in 10ng/ml GM-CSF (Peprotech), with 
feeding on days 3, 6, and 8. Alternatively, bone marrow cells were cultured in 200ng/ml Flt3 ligand 
(ImmunoTools) for 8 days, with feeding on day 4. Macrophages were generated by culture of bone 
marrow cells in M-CSF (Peprotech) for 7 days, with feeding on day 3. Non-treated tissue culture 
plates were used for all cultures. Neutrophils were isolated from bone marrow by negative selection 
using microbeads (Miltenyi BioteFDFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV1HXWURSKLOVXUYLYDOin 
vitro in GM-CSF was determined by duplicate Trypan blue counts after 44hrs of culture. 
 
Reagents 
Syk inhibitor II (Calbiochem, CA, USA) and p38 inhibitor (SB203580, Cell Signaling) were used at 
ȝ0 Cytochalasin D (Calbiochem, CA, USA) ZDVXVHGDWȝJPO Bafilomycin (Sigma-Aldrich, MO, 
USA) was used at 12.5nM. IL-3 (R&D systems) was used at the concentrations indicated in the figure. 
Integrin ligands ICAM-1 (R&D systems) and Fibronectin (Calbiochem) were coated onto cell culture 
plates at 3µg/ml and 5µg/ml, respectively, by incubation at 4°C overnight. 
 
Static adhesion assays 
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ICAM-ȝJPO5	'6\VWHPV, MN, USA) RUL&EȝJPO5	'6\VWHPV, MN, USA) were coated in 
duplicate/triplicate onto flat-bottomed 96-well Maxisorp plates (Nunc) overnight at 4°C. Wells were 
blocked with 3% human serum albumin for 1hr 15min at 37°C. DC were resuspended at 2x106 
cells/ml in binding medium (RPMI plus 0.1% bovine serum albumin, 40mM Hepes and 2mM MgCl2) 
and stimulated, where indicated, with 200nM PdBu (Sigma-Aldrich, MO, USA). Cells were allowed to 
adhere for 20min before gentle washing and detection as in 53. 
 
Priming assays 
DCs were activated with 100ng/ml LPS (Sigma-Aldrich, MO, USA RYHUQLJKW DQG ORDGHG ZLWK ȝ0
ovalbumin peptide 323-339 (AnaSpec, CA, USA) for 90min. After washing, DCs were cultured with 
purified CD4 OT-II T cells at a ratio of 1:10. 
Moloney murine leukaemia virus H19env peptide 123-141 was emulsified in CRPSOHWH )UHXQG¶V
Adjuvant (CFA, Sigma-Aldrich, MO, USA) using a sonicator. Mice were immunized with a total of 
ȝJ SHSWLGH/CFA subcutaneously into the hind legs. Alternatively, DCs were activated with 
100ng/ml LPS (Sigma-Aldrich, MO, USA RYHUQLJKW DQG ORDGHG ZLWK ȝJPO +HQY SHSWLGH IRU
90min. A total of 1-2x106 LPS-activated peptide-loaded DCs were injected intravenously into mice. 
DCs ZHUH ORDGHG ZLWK ȝJPO 6FKLVWosomal egg antigen (SEA, in-house) or ȝJPO KHDW-killed 
Propionibacterium acnes (in-house) overnight. A total of 5x105 cells were injected into the feet of 
recipient C57Bl/6 mice. 7d post-immunization, popliteal (draining) lymph nodes were extracted, and 
FHOOV UHVWLPXODWHG ZLWK DQWLJHQV ȝJPO 6($ ȝJPO KHDW-killed P. acnes, plate-bound anti-CD3 
(clone 2C11)) in vitro for 72hr. Supernatants were taken and cytokine production analyzed by ELISA 
using paired antibody kits (ebioscience) according to standard protocols. 
 
Antigen uptake assays 
For in vitro antigen uptake by BMDCs, cells were cultured with 0.1mg/ml OVA-alexa fluor 647 (Life 
Technologies) for 2.5hrs at either 4°C or 37°C. To assess in vivo antigen uptake by DCs and 
migration to lymph nodes, mice were shaved, tape stripped 3 times, and 50µg OVA-alexa fluor 647 
injected intracutaneously. After 24hrs, draining lymph nodes were removed, and DC antigen uptake 
analyzed by flow cytometry. 
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Optical trapping 
DC-T cell interaction forces were measured using a custom optical trapping system (Glass et al, 
manuscript in preparation). The beam from a Ventus IR, 3 W, continuous wave laser (Laser Quantum, 
UK) at a wavelength of 1064 nm was expanded to just overfill a Spatial Light Modulator (SLM; 
Boulder Nonlinear Systems, CO, USA). The SLM consisted of 512x512 individually addressable 
pixels, altering the phase of the light and projecting a hologram onto the back aperture of the 
microscope objective. +RORJUDPV ZHUH FDOFXODWHG DQG GLVSOD\HG RQ WKH 6/0 XVLQJ WKH µ5HG
7ZHH]HUV¶VRIWZDUH 54 (University of Glasgow), providing flexibility to alter the position of a triple-spot 
optical trap within the field-of-view and adjust the trap positions relative to each other to reflect the 
individual cell size. The triple-spot laser beam was directed into a Nikon TE2000-U inverted 
fluorescence microscope (Nikon, U.K.). The optical tweezers were calibrated with the laser beam 
power using the escape force method 54. 
For initial contact force measurement, DCs were seeded into an Ibidi µ-slide VI 0.4 (Ibidi, Germany) 
and purified OT-II T cells added. A single T cell was optically trapped, brought into contact with a DC, 
and the shutter was immediately closed.  After 2min, the trapping laser was un-blocked and the power 
of the beam increased in increments until the T cell was separated from the DC, at which point the 
force of the trap was taken to be equal to the interaction force. For quantifying DC-T cell interactions 
after 24hrs, cells were incubated in an Ibidi µ-slide 8 well before cell pairs were identified. 
Measurements were taken as described above. 
 
Flow cytometry and tetramer staining 
For ex vivo analysis of DCs in lymphoid tissues, organs were digested in 1mg/ml collagenase type II 
(Life Technologies) with 2mM EDTA for 20-30mins at room temperature with agitation. Tetramer 
staining was performed in 96-well round-bottom plates. PE-labeled MHC class II tetramers (NIH 
tetramer core facility, USA) containing either the H19env peptide or an irrelevant peptide control were 
used at 1/100 dilution in RPMI plus 10% fetal bovine serum, for 3hr at 37°C. The following conjugated 
antibodies were used (all ebioscience, unless otherwise stated): CD18 (C71/16), CD11a (2D7), 
CD11b (M1/70), CD11c (HL3), CD80 (16-10A1), CD86 (GL1), CD40 (3/23), MHC class II 
(M5/114.15.2), CD103 (2E7), CD69 (H1.2F3), CD25 (PC61), CD44 (IM7), CD3 (145-2C11), CD4 
(RM4-5), CD8a (53-6.7), CD19 (1D3), B220 (RA3-6B2), F4-80 (BM8), Gr-1 (RB6-8C5), CCR7 (4B12), 
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GM-CSF receptor beta-common chain (K-17, Santa Cruz Biotech). All FITC-conjugated antibodies 
were used at 1:100 dilution, and all other antibodies were used at 1:200 dilution. Fc block (clone 
2.4G2, BD Biosciences, 1:100 dilution) was included in all stains. Propidium iodide or DAPI (Sigma) 
were added immediately before acquisition on an LSR Fortessa flow cytometer (Becton Dickinson). 
Data was analyzed using FlowJo software (TreeStar, OR, USA). 
 
Immunoblotting 
DCs were lysed in 1% Tx-100, 150 mM NaCl, 50 mM Tris pH 7.4, 10 mM ethylenediamine tetraacetic 
acid (EDTA), 50 mM NaF, and 1 mM sodium orthovanadate, containing protease inhibitor cocktail 
(Roche). Alternatively, DCs were fractionated into subcellular fractions using a subcellular protein 
fraction kit (Thermo Scientific, NH, USA DFFRUGLQJ WR WKH PDQXIDFWXUHU¶V LQVWUXFWLRQV. Primary 
antibodies against the following proteins were used (Cell Signaling, unless otherwise stated): p-JAK2, 
p-STAT5, p-Syk, p-p38, p-Erk, p-Akt, Akt, Src, Syk, beta-actin, beta2-integrin (Abcam, MA, USA), 
GM-CSF receptor beta-common chain (Santa Cruz Biotechnology, CA, USA), kindlin-3 (Sigma-
Aldrich, MO, USA), talin, CD9 (BD Biosciences). After incubation in horseradish peroxidase±
conjugated secondary antibodies, blots were developed by standard chemiluminescence techniques. 
All uncropped blots are shown in Supplementary Figure S7. 
 
RNA preparation and Next-generation sequencing 
RNA was prepared from DCs cultured from 3 WT and 3 knock-in mice using the NucleoSpin RNA II kit 
(Macherey-Nagel). RNA samples were analyzed by the Finnish Microarray and Sequencing Centre 
(Turku, Finland) after the quality of RNA was checked using the Bioanalyzer (Agilent). Sequencing of 
samples was performed on the Illumina HiSeq2500 using 1 x 50 bp runs on single-end libraries. 
 
Selection of differentially expressed genes 
All Sequencing data in the fastq format was analyzed using the Chipster General User Interface 55. 
6HTXHQFHVZHUHWULPPHGDWWKH¶HQGPLQLPXPVFRUHDQGILOWHUHGZLWKDPD[LPXPOHQJWKRI
bp using PRINSEQ 56. Reads were aligned using TopHat2 57 onto the Mouse genome (mm10) for 
each sample (total genes 37315) and the aligned reads per gene were counted using HTseq. 
Differential expression analysis was performed by negative binomial distribution using edgeR 58 and 
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DESeq 59 software. Common genes chosen by both these software packages were chosen and those 
genes which had an expression level of less than 10 RPKM (Reads per kilobase per million reads) in 
at least one of the up-regulated samples were discarded. This left a total of 855 genes expressed 
higher in WT DCs and 862 genes expressed higher in knock-in DCs.  
 
Comparison with resident and migratory DCs 
Differentially expressed genes from migratory and resident DCs identified from a previous microarray 
study 29 were downloaded (Supplementary dataset S3).  Genes which were represented more than 
once through multiple Microarray probes were combined and genes without an ENSMUS number 
were removed. This left a total of 249 genes up-regulated in migratory DCs and 93 genes up-
regulated in resident DCs. The identities of these genes were then compared with the list of 
differentially expressed genes from our study.  
 
Statistical analysis 
7KH 6WXGHQW¶V -tailed t-test, Mann-Whitney test, ANOVA test (Graphpad Prism, CA, USA), and 
Hypergeometric test (GeneProf) were used to calculate statistical significance. All p-values are shown 
as <0.05 *, <0.01 **, <0.005 ***. 
22 
 
Acknowledgements 
We thank Angela Marley and Lauren Webb for help with experiments; Matthew MacPherson, and 
Simon Arthur for useful discussions. This work was supported by BBSRC, Arthritis Research UK, 
Tenovus Scotland, The Anonymous Trust, the Academy of Finland, Biocentrum Helsinki (all to S.C.F), 
the Ella & Georg Ehrnrooth Foundation (to V.L.M.), MRC (to C.G.-B. and A.S.M.). The authors have 
no conflicting financial interest. 
 
 
Author contributions: V.L.M contributed to planning the study, performed experiments and analyzed 
data. M.J.J, K.G., P.C., D.G.G., H.S.L., T.S., C.G-B. performed experiments and analyzed data or 
helped with experiments. C.W. provided vital materials for the study. O.R.M. planned and performed 
experiments and analyzed data. A.S.M. planned and supervised some experiments. S.C.F. planned 
and supervised the study, performed experiments and analyzed data. V.L.M and S.F. wrote the 
paper. All other authors read and commented on the manuscript. 
  
23 
 
References 
1 Morrison, V. L. et al. The beta2 integrin-kindlin-3 interaction is essential for T-cell homing 
but dispensable for T-cell activation in vivo. Blood 122, 1428-1436, doi:10.1182/blood-2013-
02-484998 (2013). 
2 Wernimont, S. A. et al. Contact-dependent T cell activation and T cell stopping require talin1. 
J Immunol 187, 6256-6267, doi:jimmunol.1102028 [pii] 
10.4049/jimmunol.1102028 (2011). 
3 Grabbe, S. et al. Beta2 integrins are required for skin homing of primed T cells but not for 
priming naive T cells. J Clin Invest 109, 183-192, doi:10.1172/JCI11703 (2002). 
4 Andrew, D. P. et al. Transendothelial migration and trafficking of leukocytes in LFA-1-
deficient mice. Eur J Immunol 28, 1959-1969, doi:10.1002/(SICI)1521-
4141(199806)28:06<1959::AID-IMMU1959>3.0.CO;2-4 [pii] 
10.1002/(SICI)1521-4141(199806)28:06&#60;1959::AID-IMMU1959&#62;3.0.CO;2-4 (1998). 
5 Kandula, S. & Abraham, C. LFA-1 on CD4+ T cells is required for optimal antigen-dependent 
activation in vivo. J Immunol 173, 4443-4451, doi:173/7/4443 [pii] (2004). 
6 Lammermann, T. et al. Rapid leukocyte migration by integrin-independent flowing and 
squeezing. Nature 453, 51-55, doi:nature06887 [pii] 
10.1038/nature06887 (2008). 
7 Varga, G. et al. Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation. Blood 109, 
661-669, doi:blood-2005-12-023044 [pii] 
10.1182/blood-2005-12-023044 (2007). 
8 Balkow, S. et al. LFA-1 activity state on dendritic cells regulates contact duration with T cells 
and promotes T-cell priming. Blood 116, 1885-1894, doi:blood-2009-05-224428 [pii] 
10.1182/blood-2009-05-224428 (2010). 
9 Bai, Y. et al. Integrin CD11b negatively regulates TLR9-triggered dendritic cell cross-priming 
by upregulating microRNA-146a. J Immunol 188, 5293-5302, doi:10.4049/jimmunol.1102371 
(2012). 
10 Ehirchiou, D. et al. CD11b facilitates the development of peripheral tolerance by suppressing 
Th17 differentiation. J Exp Med 204, 1519-1524, doi:jem.20062292 [pii] 
10.1084/jem.20062292 (2007). 
11 Han, C. et al. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by 
activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 11, 
734-742, doi:10.1038/ni.1908 
ni.1908 [pii] (2010). 
12 Wang, L. et al. Indirect inhibition of Toll-like receptor and type I interferon responses by 
ITAM-coupled receptors and integrins. Immunity 32, 518-530, 
doi:10.1016/j.immuni.2010.03.014 
S1074-7613(10)00121-4 [pii] (2010). 
13 Ling, G. S. et al. Integrin CD11b positively regulates TLR4-induced signalling pathways in 
dendritic cells but not in macrophages. Nature communications 5, 3039, 
doi:10.1038/ncomms4039 (2014). 
14 Fagerholm, S. C., Hilden, T. J., Nurmi, S. M. & Gahmberg, C. G. Specific integrin alpha and 
beta chain phosphorylations regulate LFA-1 activation through affinity-dependent and -
independent mechanisms. J Cell Biol 171, 705-715, doi:jcb.200504016 [pii] 
10.1083/jcb.200504016 (2005). 
15 Takala, H. et al. Beta2 integrin phosphorylation on Thr758 acts as a molecular switch to 
regulate 14-3-3 and filamin binding. Blood 112, 1853-1862, doi:blood-2007-12-127795 [pii] 
10.1182/blood-2007-12-127795 (2008). 
16 Svensson, L. et al. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 
affecting integrin activation. Nat Med 15, 306-312, doi:nm.1931 [pii] 
10.1038/nm.1931 (2009). 
24 
 
17 Kiema, T. et al. The molecular basis of filamin binding to integrins and competition with talin. 
Mol Cell 21, 337-347, doi:S1097-2765(06)00031-1 [pii] 
10.1016/j.molcel.2006.01.011 (2006). 
18 Lim, J. et al. An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. Mol 
Biol Cell 18, 976-985, doi:E06-09-0813 [pii] 
10.1091/mbc.E06-09-0813 (2007). 
19 Moser, M. et al. Kindlin-3 is required for beta2 integrin-mediated leukocyte adhesion to 
endothelial cells. Nat Med 15, 300-305, doi:10.1038/nm.1921 
nm.1921 [pii] (2009). 
20 Malinin, N. L. et al. A point mutation in KINDLIN3 ablates activation of three integrin 
subfamilies in humans. Nat Med 15, 313-318, doi:10.1038/nm.1917 
nm.1917 [pii] (2009). 
21 Treanor, B. et al. The membrane skeleton controls diffusion dynamics and signaling through 
the B cell receptor. Immunity 32, 187-199, doi:10.1016/j.immuni.2009.12.005 (2010). 
22 Bottcher, R. T. et al. Sorting nexin 17 prevents lysosomal degradation of beta1 integrins by 
binding to the beta1-integrin tail. Nat Cell Biol 14, 584-592, doi:10.1038/ncb2501 (2012). 
23 Hida, S. et al. Fc receptor gamma-chain, a constitutive component of the IL-3 receptor, is 
required for IL-3-induced IL-4 production in basophils. Nat Immunol 10, 214-222, doi:ni.1686 
[pii] 
10.1038/ni.1686 (2009). 
24 Horwitz, B. H., Mizgerd, J. P., Scott, M. L. & Doerschuk, C. M. Mechanisms of granulocytosis 
in the absence of CD18. Blood 97, 1578-1583 (2001). 
25 Gomez, J. C. & Doerschuk, C. M. The role of CD18 in the production and release of 
neutrophils from the bone marrow. Lab Invest 90, 599-610, doi:10.1038/labinvest.2010.4 
(2010). 
26 Stark, M. A. et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 
and IL-17. Immunity 22, 285-294, doi:10.1016/j.immuni.2005.01.011 (2005). 
27 Scharffetter-Kochanek, K. et al. Spontaneous skin ulceration and defective T cell function in 
CD18 null mice. J Exp Med 188, 119-131 (1998). 
28 Kimura, A. et al. The transcription factors STAT5A/B regulate GM-CSF-mediated 
granulopoiesis. Blood 114, 4721-4728, doi:10.1182/blood-2009-04-216390 (2009). 
29 Miller, J. C. et al. Deciphering the transcriptional network of the dendritic cell lineage. Nat 
Immunol 13, 888-899, doi:10.1038/ni.2370 (2012). 
30 Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large 
gene lists using DAVID bioinformatics resources. Nat Protoc 4, 44-57, 
doi:10.1038/nprot.2008.211 (2009). 
31 Choi, E. Y. et al. Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 
14-3-3 proteins. Blood 111, 3607-3614, doi:blood-2007-07-103077 [pii] 
10.1182/blood-2007-07-103077 (2008). 
32 Winzler, C. et al. Maturation stages of mouse dendritic cells in growth factor-dependent 
long-term cultures. J Exp Med 185, 317-328 (1997). 
33 Unternaehrer, J. J., Chow, A., Pypaert, M., Inaba, K. & Mellman, I. The tetraspanin CD9 
mediates lateral association of MHC class II molecules on the dendritic cell surface. Proc Natl 
Acad Sci U S A 104, 234-239, doi:10.1073/pnas.0609665104 (2007). 
34 Elcombe, S. E. et al. Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent 
pathway and promotes the induction of regulatory macrophage markers. PLoS One 8, 
e60086, doi:10.1371/journal.pone.0060086 
PONE-D-12-30284 [pii] (2013). 
35 MacDonald, A. S. & Maizels, R. M. Alarming dendritic cells for Th2 induction. J Exp Med 205, 
13-17 (2008). 
25 
 
36 LeibundGut-Landmann, S. et al. Syk- and CARD9-dependent coupling of innate immunity to 
the induction of T helper cells that produce interleukin 17. Nat Immunol 8, 630-638, 
doi:ni1460 [pii] 
10.1038/ni1460 (2007). 
37 Robinson, M. J. et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 
responses to fungal infection. J Exp Med 206, 2037-2051, doi:jem.20082818 [pii] 
10.1084/jem.20082818 (2009). 
38 Cook, P. C. et al. Alternatively activated dendritic cells regulate CD4+ T-cell polarization in 
vitro and in vivo. Proc Natl Acad Sci U S A 109, 9977-9982, doi:1121231109 [pii] 
10.1073/pnas.1121231109 (2012). 
39 Groom, J. R. et al. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize 
CD4+ T helper 1 cell differentiation. Immunity 37, 1091-1103, doi:S1074-7613(12)00453-0 
[pii] 
10.1016/j.immuni.2012.08.016 (2012). 
40 Xue, Z. H., Feng, C., Liu, W. L. & Tan, S. M. A role of kindlin-3 in integrin alphaMbeta2 
outside-in signaling and the Syk-Vav1-Rac1/Cdc42 signaling axis. PLoS One 8, e56911, 
doi:10.1371/journal.pone.0056911 (2013). 
41 Mattila, P. K. et al. The actin and tetraspanin networks organize receptor nanoclusters to 
regulate B cell receptor-mediated signaling. Immunity 38, 461-474, 
doi:10.1016/j.immuni.2012.11.019 (2013). 
42 Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673-687, 
doi:S0092867402009716 [pii] (2002). 
43 Morone, N. et al. Three-dimensional reconstruction of the membrane skeleton at the plasma 
membrane interface by electron tomography. J Cell Biol 174, 851-862, 
doi:10.1083/jcb.200606007 (2006). 
44 Boonstra, A. et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in 
directing T helper type 1 and 2 cell development: dependency on antigen dose and 
differential toll-like receptor ligation. J Exp Med 197, 101-109 (2003). 
45 Soares, H. et al. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an 
IL-12-independent but CD70-dependent mechanism in vivo. J Exp Med 204, 1095-1106, 
doi:10.1084/jem.20070176 (2007). 
46 Gao, Y. et al. Control of T helper 2 responses by transcription factor IRF4-dependent 
dendritic cells. Immunity 39, 722-732, doi:10.1016/j.immuni.2013.08.028 (2013). 
47 Perona-Wright, G. et al. A pivotal role for CD40-mediated IL-6 production by dendritic cells 
during IL-17 induction in vivo. J Immunol 182, 2808-2815, doi:182/5/2808 [pii] 
10.4049/jimmunol.0803553 (2009). 
48 Leon, F. et al. Antibodies to complement receptor 3 treat established inflammation in 
murine models of colitis and a novel model of psoriasiform dermatitis. J Immunol 177, 6974-
6982, doi:177/10/6974 [pii] (2006). 
49 Abdelbaqi, M. et al. Regulation of dextran sodium sulfate induced colitis by leukocyte beta 2 
integrins. Lab Invest 86, 380-390, doi:3700398 [pii] 
10.1038/labinvest.3700398 (2006). 
50 Uzel, G. et al. Reversion mutations in patients with leukocyte adhesion deficiency type-1 
(LAD-1). Blood 111, 209-218, doi:blood-2007-04-082552 [pii] 
10.1182/blood-2007-04-082552 (2008). 
51 D'Agata, I. D., Paradis, K., Chad, Z., Bonny, Y. & Seidman, E. Leucocyte adhesion deficiency 
presenting as a chronic ileocolitis. Gut 39, 605-608 (1996). 
52 Uzel, G., Kleiner, D. E., Kuhns, D. B. & Holland, S. M. Dysfunctional LAD-1 neutrophils and 
colitis. Gastroenterology 121, 958-964, doi:S0016508501171635 [pii] (2001). 
26 
 
53 Matthews, S. A. et al. Protein kinase D isoforms are dispensable for integrin-mediated 
lymphocyte adhesion and homing to lymphoid tissues. Eur J Immunol 42, 1316-1326, 
doi:10.1002/eji.201142004 (2012). 
54 Gibson, G. M. et al. A compact holographic optical tweezers instrument. Rev Sci Instrum 83, 
113107, doi:10.1063/1.4768303 (2012). 
55 Kallio, M. A. et al. Chipster: user-friendly analysis software for microarray and other high-
throughput data. BMC genomics 12, 507, doi:10.1186/1471-2164-12-507 (2011). 
56 Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. 
Bioinformatics 27, 863-864, doi:10.1093/bioinformatics/btr026 (2011). 
57 Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, 
deletions and gene fusions. Genome biology 14, R36, doi:10.1186/gb-2013-14-4-r36 (2013). 
58 Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for 
differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140, 
doi:10.1093/bioinformatics/btp616 (2010). 
59 Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome 
biology 11, R106, doi:10.1186/gb-2010-11-10-r106 (2010). 
 
 
  
27 
 
Figure Legends 
 
Figure 1: The integrin-kindlin link in DCs restricts T cell activation. WT and knock-in (KI) mice 
were immunized subcutaneously with H19env peptide emulsified in CFA, and the T cell response in 
the spleen and inguinal (draining) lymph nodes analyzed using MHC class II tetramers 9d later. Each 
data point represents an individual mouse, with mean displayed, pooled from 2 independent 
experiments, with 5 mice per group per experiment. Control groups received no immunization. (B) WT 
or KI resting peptide-loaded BMDCs were cultured with CD4 OT-II T cells in vitro at a ratio of 1:10. T 
cell expression of CD69 (on day 1), CD25 (on day 2) and CD44 (on day 4) was analyzed. Solid line ± 
WT DCs, dashed line ± KI DCs. Data is representative of N=4. (C) WT or KI BMDCs were pulsed with 
1mg/ml OVA or left un-pulsed before addition of OVA-specific OT-II T cells. The force required to 
separate DCs and T cells after 2mins or 24hrs of contact was determined. Each data point represents 
a single cell, with cells taken from 2 mice, and median indicated. p-values were calculated using the 
Mann-Whitney test. (D) BMDC adhesion to ICAM-1 and iC3b was measured by static adhesion 
assay. N=4-7. Error bars indicate SEM. (E) BMDCs were imaged after 10d of culture in GM-CSF. 
Images are representative of N=5. Scale bar is 100Pm. (F) WT or KI LPS-activated, peptide-loaded 
BMDCs were adoptively transferred into WT recipient mice intravenously, and the T cell response in 
the spleen measured 7d later using MHC class II tetramers. Each data point indicates an individual 
mouse, with mean displayed. The control group received no adoptive transfer. Data is pooled from 2 
independent experiments, with 5 mice per group in each experiment. In (A), (D) and (F) significance 
YDOXHVZHUHFDOFXODWHGXVLQJWKH6WXGHQW¶Vt-test. All p-values are shown as <0.05 *, <0.01 **, <0.005 
***. 
 
Figure 2: Beta2-integrin knock-in DCs have elevated responsiveness to GM-CSF. (A) Expression 
of CD80, CD86, CD40 and MHC class II by WT (solid line) and KI (dashed line) BMDCs after 24hrs 
stimulation with 10ng/ml GM-CSF or 100ng/ml LPS. Histograms are representative of N=4. Shaded 
line ± isotype control. (B) Expression of activation markers by WT and KI BMDCs following 24hr 
stimulation with GM-CSF or LPS. N=4. (C) Cytokine production by WT and KI DCs was measured 
after 24hr stimulation with GM-CSF or LPS. N=3-5. ND = not detectable. (D) Surface expression of 
GM-CSF receptor by WT and KI BMDCs, showing representative histogram (WT solid line; KI dashed 
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line; isotype control shaded line) and pooled data N=3 (dashed line represents isotype control). (E) 
WT and KI BMDC were starved of GM-CSF for 60 min and then stimulated for the indicated times with 
10ng/ml GM-CSF, and analyzed for pJAK2 and pSTAT5 by Western blotting. Representative of N=3. 
(F) WT and KI BMDCs were lysed following 3hr stimulation with fresh addition of 10ng/ml GM-CSF to 
DC cultures (without GM-CSF starvation), and analyzed for phosphorylated (p-) signaling molecules 
or Akt (loading control) by Western blotting. Data shows N=2, and is representative of N=4. (G) WT 
and KI DCs were stimulated with 100ng/ml LPS for up to 60min before lysis. Signaling molecules 
were analyzed by Western blotting. Data represents N=3. All error bars show SEM and significance 
YDOXHVZHUHFDOFXODWHGXVLQJWKH6WXGHQW¶Vt-test. All p-values are shown as <0.05 *, <0.01 **, <0.005 
***. 
 
Figure 3: Beta2-integrin knock-in DCs have a mature migratory phenotype in vitro. (A) Heat 
map of transcripts identified by RNAseq which show at least 2-fold differences in expression between 
WT and KI BMDCs. N=3. (B) Expression of biologically relevant genes in WT and KI BMDCs 
identified by RNAseq. N=3. (C) WT and KI BMDCs were incubated with 0.1mg/ml of OVA-alexa fluor 
647 for 2.5hrs at either 4°C (4deg) or 37°C (37deg). Antigen uptake was then measured by flow 
cytometry. N=7. (D) CCR7 expression by WT and KI BMDCs was determined by flow cytometry, with 
representative histogram (WT solid line; KI dashed line; isotype control shaded line) and pooled data 
from N=3. (E) Venn diagram showing numbers and overlap of the gene expression profiles of in vivo 
migratory DCs 29 and KI GM-CSF-cultured BMDCs. Significance values in (C-D) were calculated 
XVLQJWKH6WXGHQW¶Vt-test, and the p-value in (E) was calculated by Hypergeometric test. All p-values 
are shown as <0.05 *, <0.01 **, <0.005 ***. 
 
Figure 4: Beta2-integrin knock-in DCs have a mature migratory phenotype in vivo. (A) Numbers 
of CD11c+ MHC class II+ DCs were quantified in lymphoid tissues of WT and KI mice by flow 
cytometry. N=4. (B) Resident and migratory DCs were quantified in WT and KI spleen and peripheral 
lymph nodes. Resident (CD8+ or CD8-) DCs were determined as CD3- CD19- B220- CD11c+ MHC 
class II+. Migratory DCs (CD103+ CD11b- or CD103- CD11b+) were identified as CD19- CD3- CD4- 
CD11c+ MHC class II+. N=5. (C) Percentages of CD19+ B cells and CD3+ T cells in the spleens and 
lymph nodes of CFA immunized mice 9d post-immunization. N=5. (D) Percentages of CD11c+ MHC 
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class II+ DCs in lymph nodes of naïve and CFA immunized mice 24hrs post-immunization. N=3. (E) 
Expression of CD86 and CD40 on total splenic DCs was examined in resting and CFA-immunized WT 
and KI mice 24hrs post-immunization. N=3. (F) WT and KI mice received OVA-alexa fluor 647 
intracutaneously and 24hrs later the draining lymph nodes were analyzed for OVA+ DCs by flow 
cytometry. N=5. All HUURUEDUVVKRZ6(0DQGVLJQLILFDQFHYDOXHVZHUHFDOFXODWHGXVLQJWKH6WXGHQW¶V
t-test. All p-values are shown as <0.05 *, <0.01 **, <0.005 ***. 
 
Figure 5: Beta2-integrin-mediated ligand binding regulates DC maturation. (A) WT DCs were 
matured for 24h by LPS-stimulation and assessed for adhesion to ICAM-1 and fibronectin. N=3. (B) 
WT and beta2 null DC lysates were analyzed for p-Syk, p-Akt and Src (loading control) by Western 
blotting after 3hr GM-CSF stimulation. Shows N=2, representative of N=3. (C) Expression of CD80, 
CD86, CD40 and MHC class II by WT (solid line) and beta2 null (dashed line) DCs. Data is 
representative of N=4 mice. Shaded line ± isotype control. (D) Cytokine production by WT, KI and 
beta2 null (KO) DCs was measured after 24hr stimulation with 10ng/ml GM-CSF or 100ng/ml LPS. 
N=3. ND = not detectable. (E) WT DCs were adhered on plates or detached and placed in tubes and 
stimulated for 3h with GM-CSF and analyzed for GM-CSF receptor signaling by Western blotting. 
Shows N=2, representative of N=3. (F) WT DCs were adhered on plates or detached in tubes for 3hr 
before being stimulated with GM-CSF for a further 24hr. Expression of CD80, CD86, CD40 and MHC 
class II was then measured using flow cytometry. N=6. (G) IL-12p40 production by adhered and 
detached WT DCs in response to GM-CSF, and IL-10 production following LPS stimulation. N=6. (H-I) 
WT and KI BMDCs were placed on ICAM-1, fibronectin (Fn), non-treated petri dishes or tissue 
culture-treated plates (TC) for 3hrs, and then stimulated with GM-CSF for a further 24hrs. CD86 
expression (H) and IL-12p40 production (I) were then measured. N=3. All error bars show SEM and 
VLJQLILFDQFH YDOXHV ZHUH FDOFXODWHG XVLQJ WKH 6WXGHQW¶V t-test. All p-values are shown as <0.05 *, 
<0.01 **, <0.005 ***. 
 
Figure 6: Integrin-kindlin-actin links regulate DC maturation. (A) DC lysates were separated into 
subcellular fractions using a commercial kit (Thermo Scientific), as described in the methods section, 
and then analyzed by Western blotting. C=cytoplasmic, M=membrane, CS=cytoskeleton. Shows N=1 
and is representative of N=4. (B) p-Syk, p-Erk and Src (loading control) levels in lysates from WT DCs 
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stimulated with GM-CSF HLWKHU XQWUHDWHG RU WUHDWHG ZLWK ȝJPO F\WRFKDODVLQ ' &\WR' 1  LV
shown, and is representative of N=3. (C) WT DC expression of CD86 and CD40 in plates and tubes, 
with treatment with CytoD. N=4. (D) IL-12p40 production by WT DCs in plates and tubes, with CytoD 
treatment, following GM-CSF stimulation. N=4. Error bars show 6(07KH6WXGHQW¶Vt-test was used 
to calculate p-values. 
 
Figure 7: Syk is partly responsible for the mature DC phenotype. (A-B) WT and KI BMDCs were 
put in plates or tubes and pre-treated with Syk and p38 inhibitors for 30mins before the addition of 
10ng/ml GM-CSF or 100ng/ml LPS for 24hrs. Expression of CD80, CD86, CD40 and MHC class II 
was then analyzed by flow cytometry, N=4-6 (A). Levels of IL-12p40 and IL-10 were measured in 
culture supernatants after GM-CSF (for IL-12p40) or LPS (for IL-10) stimulation. N=4-6. (C) WT, KI 
and beta2 null (KO) DCs were pre-treated with Syk inhibitor II for 30mins, and then stimulated with 
GM-CSF (for IL-12p40) or LPS (for IL-10) for 24hrs. N=3. ND = not detectable. In all cases error bars 
VKRZ6(07KH6WXGHQW¶V t-test was used to calculate p-values. All p-values are shown as <0.05 *, 
<0.01 **, <0.005 ***. 
 
Figure 8: Beta2-integrin knock-in DCs induce elevated Th1 responses. (A) WT or KI DCs were 
loaded with SEA or heat-killed P. acnes prior to being transferred into WT recipient mice 
subcutaneously into the foot. On day 7, the popliteal (draining) lymph nodes were removed, and the T 
cell response analyzed by measuring cytokine production following in vitro restimulation with antigen. 
Presented data is from one experiment, and is representative of 2 independent experiments, with 5 
mice per group per experiment. (B) CXCL10 production was measured after 24hrs stimulation of WT 
and KI DCs in the presence or absence of the Syk inhibitor. N=4. In all cases, error bars indicate 
SEM. 7KH6WXGHQW¶Vt-test was used to calculate p-values. NS = not significant. ND = not detectable. 
All p-values are shown as <0.05 *, <0.01 **, <0.005 ***. 








